Fig. 1

Timeline of the clinical development of inotuzumab ozogamicin in acute lymphoblastic leukemia. For context, approval dates for other novel immunotherapies in adult B-cell acute lymphoblastic leukemia are also shown
Timeline of the clinical development of inotuzumab ozogamicin in acute lymphoblastic leukemia. For context, approval dates for other novel immunotherapies in adult B-cell acute lymphoblastic leukemia are also shown